Clinical Features and Prognostic Analysis of Chronic Kidney Disease Stage 3-5 with Massive Proteinuria

LIU Hong,DING Xiao-qiang,XU Xia-lian,FANG Yi,YUAN Min,ZHANG Xiao-yan,JI Jun

DOI: https://doi.org/10.3969/j.issn.1672-8467.2010.06.008

2010-01-01

Abstract:Objective To analyze the clinicopathological features and prognosis of stage 3-5 chronic kidney disease(CKD) with massive proteinuria.Methods This retrospective study analyzed the presenting features,renal histology and outcome of 174 stage 3-5 CKD patients compare the difference between patients with massive proteinuria(proteinuria≥3.0 g/24 h,group A) and patients without massive proteinuria(proteinuria3.0 g/24 h,group B).Results Compared with group B,there were more patients with stage 4-5 CKD in group A(95.92% vs.86.84%,P0.05) when renal biopsy.Most patients in group A were glomerulonephritis,while few were tubulointerstitial disease and vascular disease.IgA nephritis patients with massive proteinuria had more active lesions.After glucocorticoid or immunosuppressant treatment,24 h proteinuria in group A was decreased [post-therapy vs.pre-therapy:(2.77±1.98)g/24 h vs.(6.21±3.37)g/24 h,P0.01],serum albumin increased [post-therapy vs.pre-therapy:(38.73±5.86)g/L vs.(31.42±7.63)g/L,P0.01],estimated glomerular filtration rate(eGFR) improved [post-therapy vs.pre-therapy:(34.69±26.35) vs.(20.25±6.87)mL·min-1·1.73 m-2,P0.01].Kidney survival of group A was lower(50.75% vs.70.83%,P0.05).Conclusions Stage 3-5 CKD patients need renal biopsy to definite pathological diagnosis when conditions permit.Stage 3-5 CKD patients with massive proteinuria had different clinical presenting features,different pathologic type,more active histological lesions and poorer renal survival rate compare with those without massive proteinuria.Glucocorticoid and immunosuppressant treatment can reduce urokinase protein and improve renal function in renal functionsome patients.Renal biopsy is also necessary for the diagnosis.